Clinical Trial Update: A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial update on intravenous Erwinaze for patients with allergy to frontline asparaginase therapy in acute lymphoblastic leukemia or lymphoblastic lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma

Drugs mentioned

• Erwinaze (Asparaginase from Erwinia chrysanthemi)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2021-06-23